Patent details

300915 Product Name: Daratumumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300915
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2567976
Status:
SPC granted but not yet in force
Application number:
300915
Procedural language:
Dutch
First Applicant Residence Country:
Denmark (DK)

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1101/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
24/05/2016
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
28/11/2017
First Marketing Authorization date:
24/05/2016
Grant date:
26/10/2020
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
04/12/2017
SPC/SPC Extension Expiration Date:
22/03/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
28/11/2017
 
 

 

Name:
Genmab A/S
Address:
Kalvebod Brygge 43, 1560 Copenhagen V, Denmark (DK)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
28/11/2017
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
44/20
Publication date:
28/10/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
49/17
Publication date:
06/12/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/03/2026
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
26/10/2020 Outgoing Correspondence Decision grant 1 PDF /6/3/7/9/1/0800219736/docs/300915_0_374456l504a.pdf
26/10/2020 SPC Documents Certificate SPC 1 PDF /6/3/7/9/1/0800219736/docs/300915_10_supplprotectioncertificate20201026013150675.pdf
16/09/2020 SPC Documents Accompanying letter SPC 1 PDF /6/3/7/9/1/0800219736/docs/300915_1_supplprotectioncertificate20200916121632133.pdf
10/08/2020 Outgoing Correspondence Letter to applicant 1 PDF /6/3/7/9/1/0800219736/docs/300915_5_359465l173.pdf
10/08/2020 SPC Documents Accompanying letter SPC 1 PDF /6/3/7/9/1/0800219736/docs/300915_11_supplprotectioncertificate20200810115642462.pdf
14/05/2020 Outgoing Correspondence Letter to applicant 2 PDF /6/3/7/9/1/0800219736/docs/300915_8_344190l173.pdf
06/12/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /6/3/7/9/1/0800219736/docs/300915_13_178747l174.pdf
29/11/2017 SPC Documents Annex SPC 4 PDF /6/3/7/9/1/0800219736/docs/300915_2_supplprotectioncertificate20200511122541559.pdf
29/11/2017 SPC Documents Marketing Authorization SPC 4 PDF /6/3/7/9/1/0800219736/docs/300915_3_supplprotectioncertificate20171204031639033.pdf
29/11/2017 SPC Documents Annex SPC 14 PDF /6/3/7/9/1/0800219736/docs/300915_4_supplprotectioncertificate20171204031639417.pdf
29/11/2017 SPC Documents Accompanying letter SPC 1 PDF /6/3/7/9/1/0800219736/docs/300915_6_supplprotectioncertificate20171204031639509.pdf
29/11/2017 Application Form First filed application form 2 PDF /6/3/7/9/1/0800219736/docs/300915_9_applicationform20171204031638805.pdf
28/11/2017 SPC Documents Summary of the characteristics of the product 14 PDF /6/3/7/9/1/0800219736/docs/300915_7_supplprotectioncertificate20171204031639213.pdf
28/11/2017 SPC Documents Annex SPC 4 PDF /6/3/7/9/1/0800219736/docs/300915_12_supplprotectioncertificate20171204031639316.pdf